Moolec Science SA Ordinary Shares (MLEC) — 分析摘要
Moolec Science SA Ordinary Shares（MLEC）的市值为5.39百万美元，最近一年的营收同比增长了+521.5%。净利润率为-130.0%。当前市盈率为-0.7倍。
核心要点
- 营收同比变化+521.5%
- 净利润率-130.0%
- 市盈率-0.7倍
MLEC的营收增长为+521.5%，市盈率为-0.7倍。
Moolec Science SA Ordinary Shares (MLEC)
更新 — ET · 来源 POLYGON
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
利息保障倍数为 -219.9x — 盈利不足以覆盖利息支出
营业利润率为 -160.8% — 严重经营亏损
净利率为 -130.0% — 亏损超过收入（可能含一次性费用）
最新报表显示自由现金流为负。
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
员工人数
72
Exchange
XNAS
需要至少 3 年年度财务数据来评估竞争壁垒。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。